Navigation Links
Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009
Date:9/21/2009

SAN FRANCISCO, Sept. 21 /PRNewswire/ -- The TCT 2009 meeting will feature an unusual amount of novel information about Vulnerable Coronary Artery Plaque, the structure widely considered to be the primary cause of acute coronary events, the leading cause of death in the developed world. The concept of Vulnerable Plaque has been a topic of study for over 2 decades. TCT will showcase progress on a number of diagnostic catheters designed to identify the lipid core plaques that are widely suspected to be vulnerable.

  • Monday, September 21 -- Four presentations in the day-long Vulnerable Plaque Symposium describing the experience with LipiScan, a novel near-infrared spectroscopy catheter (InfraReDx, Inc.) approved in 2008 by the FDA for identification of lipid core plaques. (Room 131)
  • Thursday, September 24 -- Dr. Gregg Stone will present the results of the 3 year follow-up of suspected vulnerable plaques in the Prospect Trial, a study of over 700 patients with multi-vessel ultrasound (Virtual Histology, Volcano, Inc.) measurements at baseline. This major trial is the first, large, long-term study of the hypothesis that harmful vulnerable plaques can be identified before they cause a coronary event. (Room 300)

In 1989, Dr. James Muller and colleagues introduced the term "Vulnerable Plaque" to describe a plaque at high risk of disruption that leads to coronary thrombosis. Dr. Muller, CEO of InfraReDx, Inc. participated in the company's founding in 1998 for the purpose of developing a spectroscopic catheter to detect vulnerable plaque. Dr. Muller will be available at TCT to comment on the important developments related to vulnerable plaque reported at the meeting, including commentary on the outcome of the Prospect Trial. Dr. Muller and his colleague, Jim Dillon, Vice-President of Sales and Marketing at InfraReDx, Inc. will be available for comment on the use
'/>"/>

SOURCE InfraReDx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Web Site Will Help Pennsylvanians Learn About, Protect Against Novel H1N1 Flu
2. The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six-Fold to Over $3.2 Billion in 2018
3. Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid
4. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
5. Fifteenth US Patent Issued for aTyr Pharma Novel Biotherapeutic
6. Solution to PREVENT Novel H1N1 (Swine Flu) From Closing Down Schools!
7. The Cosmetic Bootcamp LLC Announces Novel Presentations at Its 3rd Annual Marketing and Management Symposium
8. Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy
9. Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates
10. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
11. Exsulin Corporation Announces Publication of Phase 2 Trial Results for Novel Islet Regeneration Treatment in Type 1 & Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 Muscular Dystrophy ... Biomedical Engineering at Duke University, recently announced a ... and young men with Duchenne muscular dystrophy (DMD). ... Communications, and Gersbach will discuss their implications at ... 11-14 in Washington, D.C. , Background: Gersbach ...
(Date:2/27/2015)... According to the report, the annual revenue ... in 2013 rose by 31.9%. However, in the first ... generated by the industry was recorded at RMB3.623 billion ... industry in 2013. , View Full Report at ... oral industry as a branch of medical industry that ...
(Date:2/27/2015)... Lake City, UT (PRWEB) February 27, 2015 ... Best and Worst Commuter Cities in Florida " ... traffic data from the 2013 U.S. Census Bureau ... 10,000 at the time of the survey. , ... city level, including methods of commuting and a ...
(Date:2/27/2015)... On time and under budget, the doors ... Inside and out, the nearly 900,000-square-foot facility makes good ... the tornado-ravaged St. John’s Regional Medical Center with a ... just 46 months after the tornado hit Joplin, which ... to plan, design and construct a similarly sized hospital,” ...
(Date:2/27/2015)... Fairfax, VA (PRWEB) February 27, 2015 ... currently accepting applications for its next class of Fellows ... the field of radiology business management. , Since ... the significant contributions made by RBMA members to the ... is a prestigious recognition because each Fellow candidate must ...
Breaking Medicine News(10 mins):Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 3Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2Health News:New Hospital Built to Stand Against Nature 2Health News:New Hospital Built to Stand Against Nature 3Health News:New Hospital Built to Stand Against Nature 4Health News:RBMA Issues Call for Fellowship Applicants 2
... with rheumatoid arthritis who undergo total knee replacement ... according to a new study by researchers at ... City. These reduced expectations, which may be unnecessary, ... postsurgical rehabilitation leading to worse outcomes, say doctors. ...
... , SATURDAY, Nov. 5 (HealthDay News) -- Exposure to certain ... for the painful joint disease known as rheumatoid arthritis, new ... one of the six most common air pollutants in the ... to be presented Wednesday at the American College of Rheumatology ...
... HealthDay Reporter , FRIDAY, Nov. 4 (HealthDay News) -- A ... identifying a gene that is critical in determining which life-saving ... by Genomic Health, results in a number of false-negatives for ... in the Journal of Clinical Oncology . ...
... Cholesterol-lowering medications may help millions fight heart ... control, according to a study presented at the American ... Boston, Nov. 3-8. In the preliminary study ... medication or statins, to 20 patients with asthma who ...
... lab cultures and mice, Johns Hopkins scientists have found that ... causes colon inflammation and increases activity of a gene ... is to expose the gut to hydrogen peroxide the ... cause DNA damage, contributing to the formation of colon tumors, ...
... role in kidney failure, and blocking the action of this ... according to researchers. "We believe these arginase inhibitors may ... the progression of, or even prevent the development of, end-stage ... Penn State College of Medicine. In the United States diabetes ...
Cached Medicine News:Health News:Rheumatoid arthritis patients have low expectations after knee replacement surgery 2Health News:Rheumatoid arthritis patients have low expectations after knee replacement surgery 3Health News:Studies Suggest Link Between Smog, Joint Disease 2Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 2Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 3Health News:ACAAI Annual Meeting abstracts: Improved outcomes for adults with allergies and asthma 2Health News:ACAAI Annual Meeting abstracts: Improved outcomes for adults with allergies and asthma 3Health News:ACAAI Annual Meeting abstracts: Improved outcomes for adults with allergies and asthma 4Health News:Common bacteria cause some colon tumors by altering peroxide-producing gene 2Health News:Research aims to prevent diabetic kidney failure 2
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015 Legislation ... includes a pharmacy provision to help prevent inappropriate prescriptions ... The Protecting the Integrity of Medicare Act (PIMA) ... Subcommittee Chairman Kevin Brady (R-TX) and Ranking ... the prescription drug abuse epidemic and implement the right ...
(Date:2/26/2015)... , Feb. 26, 2015 Research and Markets ... the "Radiation Therapy Equipment - Global Strategic Business ... This report analyzes the worldwide markets for Radiation Therapy ... Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. ... Canada , Japan ...
(Date:2/26/2015)... 2015  Spring Bank Pharmaceuticals, Inc., a clinical-stage ... of virus infections, today announced that Jonathan ... President of Finance, a newly created role.  Mr. ... activities, including financial planning and reporting, accounting and ... Jensen , President and CEO. ...
Breaking Medicine Technology:PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2
The Foundation PS knee offers a femoral option and tibial insert which provides a specially designed cam action that engages at 60 degrees of flexion to induce a smooth stable femoral roll-back motio...
Consensus Knee implants are designed to provide both joint and implant stability and allow near normal kinematics. The components are anatomic with porous and nonporous options. Six femoral/tibial an...
Scorpio CR Knee is designed to address normal knee kinematics, range of motion (ROM) and polyethylene wear....
... The TC-PLUS Solution tricompartmental total knee ... with knee arthroplasty. State-of-the-art design and manufacturing ... achieve optimum biomechanical function as well as ... polyethylene tibial insert to keep wear to ...
Medicine Products: